Full Text View
Tabular View
No Study Results Posted
Related Studies
Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis
This study is currently recruiting participants.
Study NCT00655239   Information provided by National Institute of Mental Health (NIMH)
First Received: April 7, 2008   Last Updated: May 21, 2009   History of Changes

April 7, 2008
May 21, 2009
June 2008
March 2013   (final data collection date for primary outcome measure)
Cognitive performance, as measured by a neuropsychological battery [ Time Frame: Measured at baseline, Weeks 8 and 16, and Month 6 follow-up ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00655239 on ClinicalTrials.gov Archive Site
Symptom profile, as measured by clinical interviews [ Time Frame: Measured at baseline, Weeks 8 and 16, and Month 6 follow-up ] [ Designated as safety issue: No ]
Same as current
 
Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis
Neuroscience-Guided Cognitive Remediation in Adolescents at Risk for Psychosis

This study will evaluate the effectiveness of intensive computerized cognitive training in preventing the onset of psychotic disorder and improving adaptive functioning in adolescents at high risk of schizophrenia.

Schizophrenia is a severe mental disorder that is marked by significant disruption in a person's thought and emotional processes, frequently involving psychotic features. Identifying behavioral changes and symptoms that indicate the beginning stages of schizophrenia is important for early intervention and prevention of a full psychotic episode. These initial symptoms, known as the prodromal symptoms of psychosis, may include odd behaviors, increased social withdrawal, difficulty concentrating, inappropriate emotional responses, suspicion of others, and dramatic sleep and appetite changes. Common treatments for adolescents demonstrating prodromal symptoms include forms of psychotherapy, nutritional training, and low doses of medication. As a form of psychotherapy, neuroadaptive cognitive training exercises delivered on a computer may be the most effective means of remediating the thinking difficulties of adolescents who are experiencing prodromal symptoms and are at risk for developing a first psychotic episode. This study will evaluate the effectiveness of intensive computerized neuroadaptive cognitive training exercises in preventing the onset of psychotic disorder and improving adaptive functioning in adolescents at high risk of schizophrenia.

Participation in this study will last 6 months and will involve both healthy participants and participants at high risk of schizophrenia. All participants will undergo baseline assessments that will include an interview, written tests, blood draws, and electroencephalogram (EEG) and magnetic resonance imaging (MRI) scans. Participants at high risk of schizophrenia will then be assigned randomly to receive treatment with either computerized neuroadaptive cognitive training or commercially available computer games. Healthy participants will receive treatment with computerized neuroadaptive cognitive training only. All participants will be asked to complete 60-minute sessions of their assigned treatments 5 days per week for 16 weeks. For participants receiving cognitive training, exercises will focus on improving speed and accuracy in the perception of and response to verbal and visuospatial targets. The first 8 weeks of treatment will focus on targeted cognitive training (TCT) and the second 8 weeks will focus on visuospatial training. Participants assigned to practice computer games will play standard, commercially available games, with no targeted response.

Participants will repeat baseline assessments at Weeks 8 and 16 of treatment and Month 6 of follow-up. The EEG and MRI will be repeated only at the Week 16 assessment visit. There will be a blood draw at Week 2 of treatment as well. After the Month 6 assessment, participants will be offered an opportunity to complete an additional 8 to 16 weeks of computer training with different modules.

Phase I, Phase II
Interventional
Prevention, Randomized, Double Blind (Subject, Caregiver, Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Schizophrenia
  • Behavioral: Neuroadaptive cognitive training
  • Behavioral: Computer games
  • Active Comparator: Participants will use commercially available computer games.
  • Experimental: Participants will receive targeted cognitive training with neuroplasticity-based software created by Posit Science Corporation.
  • Active Comparator: Healthy participants will receive targeted cognitive training with neuroplasticity-based software created by Posit Science Corporation.
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
100
March 2013
March 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Meets criteria from the Structured Interview of Prodromal Syndromes for the diagnosis of a prodromal syndrome
  • Good general physical health
  • English is first language
  • Clinically stable (e.g., outpatient status for at least 8 weeks before study entry;on stable doses of medications for at least 1 month before study entry)

Exclusion Criteria:

  • Confirmed neurological disorder
Both
14 Years to 25 Years
Yes
Contact: PART Program 415-476-7278
United States
 
NCT00655239
Sophia Vinogradov, MD, Professor of Psychiatry, University of California, San Francisco
R01 MH081051, DDTR B2-NDS
National Institute of Mental Health (NIMH)
 
Principal Investigator: Sophia Vinogradov, MD University of California, San Francisco; San Francisco VA Medical Center; NCIRE - The Veterans Health Research Institute
Study Director: Rachel Loewy, PhD University of California, San Francisco
Study Director: Cameron Carter, MD University of California, Davis
National Institute of Mental Health (NIMH)
May 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP